Rebecca C. Arend

Oncology
1700 6th Ave S
Irondale, AL 35210

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 155 publications

Residential Context and Survival Disparities in Black and White Women With Ovarian Cancer.

Residential Context and Survival Disparities in Black and White Women With Ovarian Cancer.

Journal: JAMA network open
Published: August 10, 2026

Palbociclib in Patients With Ovarian Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.

Palbociclib in Patients With Ovarian Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.

Journal: JCO precision oncology
Published: July 15, 2026

Oxidative DNA Damage Is Associated with Immune Remodeling and Therapeutic Response in High-Grade Serous Ovarian Cancer.

Oxidative DNA Damage Is Associated with Immune Remodeling and Therapeutic Response in High-Grade Serous Ovarian Cancer.

Journal: Cancers
Published: June 25, 2026

Jump-starting the T cell response in established tumors.

Jump-starting the T cell response in established tumors.

Journal: bioRxiv : the preprint server for biology
Published: June 12, 2026

Understanding and addressing enrollment gaps and opportunities in gynecologic oncology clinical trials: A scoping review.

Understanding and addressing enrollment gaps and opportunities in gynecologic oncology clinical trials: A scoping review.

Journal: Gynecologic oncology
Published: June 04, 2026

Application of Cobas 6800 HPV testing and qPCR utilizing three genomically-optimized primer sets for detecting HPV DNA in the blood of HPV Positive dysplasia and cancer patients.

Application of Cobas 6800 HPV testing and qPCR utilizing three genomically-optimized primer sets for detecting HPV DNA in the blood of HPV Positive dysplasia and cancer patients.

Journal: PloS one
Published: April 28, 2026

A phase Ib/II single-arm study of cabozantinib plus dostarlimab in women with recurrent gynecologic carcinosarcoma.

A phase Ib/II single-arm study of cabozantinib plus dostarlimab in women with recurrent gynecologic carcinosarcoma.

Journal: Gynecologic oncology
Published: April 13, 2026

Nurse-led visual triage against histopathology in a real-world low-resource setting cervical cancer prevention program.

Nurse-led visual triage against histopathology in a real-world low-resource setting cervical cancer prevention program.

Journal: Gynecologic oncology reports
Published: April 06, 2026

A Systematic Review and Meta-Analysis of the Association Between Depot Medroxyprogesterone Acetate and Cerebral Meningioma.

A Systematic Review and Meta-Analysis of the Association Between Depot Medroxyprogesterone Acetate and Cerebral Meningioma.

Journal: Cancers
Published: March 18, 2026

Vaginal Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology.

Vaginal Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 13, 2026

MLH1 promoter hypermethylation and associations with survival outcomes: A real-world endometrial cancer molecularly targeted therapy consortium cohort study.

MLH1 promoter hypermethylation and associations with survival outcomes: A real-world endometrial cancer molecularly targeted therapy consortium cohort study.

Journal: Gynecologic oncology
Published: February 15, 2026

Cervical Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology.

Cervical Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: February 11, 2026
Showing 1-12 of 155

Last Updated: 09/26/2026